STOCK TITAN

Vitrolife: Conference call interim report

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Vitrolife AB is scheduled to hold a conference call on April 21, 2023, at 10:00 a.m. CET, to discuss its interim report for Q1 2023. The call will be conducted in English, and registration is required to participate. During the call, key executives, including Jón Sigurdsson, Interim CEO, and Patrik Tolf, CFO, will be present. The interim report will be released at 8:00 CET on the same day, and presentation materials will be available on the company website prior to the call. A recorded version of the call will be accessible for seven days post-event.

Positive
  • Scheduled conference call indicates transparency with investors.
  • Release of interim report may provide important financial insights.
Negative
  • None.

Insights

Analyzing...

GOTHENBURG, Sweden, April 6, 2023 /PRNewswire/ -- Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q1, 2023. The presentation will be held in English.

Time: Friday 21 April, 2023 at 10.00 a.m. CET.

To attend the conference call, please use this link to register. After registration, you will be provided with telephone numbers, conference PIN, and personal PIN to access the conference.

https://event.loopup.com/SelfRegistration/registration.aspx?booking=TGbW4X4FE6OC5IgnnIS3Tv9ctcpp69DW8TuBIMLpnm4=&b=2389e96d-457b-46a8-bebb-fec356d5b031

Vitrolife Group participants:
Jón Sigurdsson, Interim CEO
Patrik Tolf, CFO

The press release for the interim report will be released at 8.00 CET on the same day.

Before the conference call, presentation material will be available at the company web page.

A recorded version of the telephone conference will be available for seven days on number +44 (0) 20 3451 9993 (International), access code 0315396#.

Gothenburg, 6 April 2023
VITROLIFE AB (publ)

Contact: 
Patrik Tolf, CFO, phone +46 (0) 31 766 90 21

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

The following files are available for download:

https://mb.cision.com/Main/1031/3748252/1973328.pdf

Conference call interim report

 

 

Cision View original content:https://www.prnewswire.com/news-releases/vitrolife-conference-call-interim-report-301791639.html

SOURCE Vitrolife AB

FAQ

When will Vitrolife AB present its Q1 2023 interim report?

Vitrolife AB will present its Q1 2023 interim report on April 21, 2023.

What time is the Vitrolife AB conference call for the interim report?

The conference call is scheduled for 10:00 a.m. CET on April 21, 2023.

Who will be speaking at the Vitrolife AB conference call?

Jón Sigurdsson, Interim CEO, and Patrik Tolf, CFO, will speak at the conference call.

How can I attend the Vitrolife AB conference call?

You can register using the link provided in the press release to attend the Vitrolife AB conference call.

When will the interim report be released to the public?

The interim report will be released at 8:00 CET on April 21, 2023.
Vitrolife

OTC:VTRLY

VTRLY Rankings

VTRLY Latest News

VTRLY Stock Data

2.44B
74.98M
Medical Devices
Healthcare
Link
Sweden
Gothenburg